CN Patent

CN112174881B — 一种奈妥匹坦的衍生物及其制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2022-06-21 · 4y expired

What this patent protects

本公开提供一种奈妥匹坦的衍生物及其制备方法。具体而言，提供式I所示化合物或其药学上可接受的盐，及其制备方法。

USPTO Abstract

本公开提供一种奈妥匹坦的衍生物及其制备方法。具体而言，提供式I所示化合物或其药学上可接受的盐，及其制备方法。

Drugs covered by this patent

fosnetupitant-chloride-hydrochloride (FOSNETUPITANT CHLORIDE HYDROCHLORIDE)

Patent Metadata

Patent number: CN112174881B
Jurisdiction: CN
Classification: —
Expires: 2022-06-21
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hengrui Medicine Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.